Latest News of MRX
Marex Group PLC (MRX) Q3 2024 Earnings Call Highlights: Robust Revenue Growth and Upgraded ...
By Yahoo! Finance |
1 week ago
Ian Lowitt, CEO, discusses a strong market environment and client balances, with Q4 expected to be slower but still robust. Future investments will be evenly spread out, with the recent debt issuance ...
Amneal Pharmaceuticals (NASDAQ:AMRX) grows 3.0% this week, taking five-year gains to 211%
By Yahoo! Finance |
2 weeks ago
Amneal Pharmaceuticals stock has shown impressive growth of 211% in five years, with a recent 19% rise. Despite profit fluctuations, its revenue has grown steadily. Shareholders are optimistic about f...
Amneal Pharmaceuticals, Inc. (AMRX) Stock Price, News, Quote & History - Yahoo Finance
By Yahoo! Finance |
1 month ago
Amneal and Metsera have formed a strategic collaboration to create and distribute a range of advanced medications for obesity and metabolic diseases worldwide. The partnership aims to expedite the dev...
-
Here's Why We're Watching Chimerix's (NASDAQ:CMRX) Cash Burn Situation
By Yahoo! Finance | 1 month agoInvestors are often attracted to unprofitable companies like Amazon, which turned profitable over time. Analyzing Chimerix's cash burn and runway, it's crucial to assess its financial health for poten...
-
Jim Cramer Says Cardinal Health Inc. (CAH) Built A More Stable Foundation And Delivered Impressive Results After Losing The OptumRx Business
By Yahoo! Finance | 2 months agoJim Cramer's bullish stock picks include Cardinal Health Inc., showing impressive growth despite challenges. Cramer emphasizes investing in exceptional companies for long-term success, highlighting th...
-
Insider Sale at Amneal Pharmaceuticals Inc (AMRX) by Executive Vice President Andrew Boyer
By Yahoo! Finance | 3 months agoAndrew Boyer, Executive VP of Amneal Pharmaceuticals Inc, sold 62,711 shares, now owning 256,670 shares. The company has seen insider selling recently, with no buys. With a market cap of $2....
-
Insider Sale at Amneal Pharmaceuticals Inc (AMRX): Executive Vice President Nikita Shah Sells ...
By Yahoo! Finance | 3 months agoAmneal Pharmaceuticals Inc has witnessed insider selling activity, with shares priced at $7.75. The company's market cap is $2.49 billion, but the stock is deemed significantly overvalued with an intr...
-
MRX Stock Price | Marex Group PLC Stock Quote (U.S.: Nasdaq) | MarketWatch
By MarketWatch | 3 months agoMarex Group Plc offers brokerage services in commodities, financials, and foreign exchange. Founded in 2005 by Mark Slade, it operates through segments like Clearing, Agency and Execution, Market Maki...
-
In spite of recent selling, insiders still control 53% of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)
By Yahoo! Finance | 3 months agoAmneal Pharmaceuticals (NASDAQ:AMRX) has 5 investors owning a majority stake of 51%. Insiders hold 53% shares, indicating control. Institutional ownership and analyst sentiments impact stock performan...
-
Drug distributor Cardinal Health to lose OptumRx contracts
By Reuters | 6 months ago(Reuters) -Cardinal Health said on Monday its contracts with UnitedHealth Group's OptumRx will not be renewed after they expire at the end of June, sending the drug distributor's shares down over 4% i...
-
Cardinal Health says contracts with UnitedHealth's OptumRx will not be renewed
By Reuters | 6 months ago(Reuters) - Cardinal Health said on Monday its pharma distribution contracts with UnitedHealth Group Inc's OptumRx unit will not be renewed after they expire at the end of June.The drug distributo...